Pages that link to "Q36690645"
The following pages link to Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1 (Q36690645):
Displaying 50 items.
- Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase (Q24529111) (← links)
- Polymerase structures and function: variations on a theme? (Q24685513) (← links)
- Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission (Q24814895) (← links)
- A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles (Q24815183) (← links)
- Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid (Q27676135) (← links)
- Ty3 reverse transcriptase complexed with an RNA-DNA hybrid shows structural and functional asymmetry (Q27689454) (← links)
- Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine (Q28342653) (← links)
- Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine (Q28367543) (← links)
- Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase (Q28367547) (← links)
- Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs (Q28367663) (← links)
- Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms (Q28367673) (← links)
- Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase (Q28368003) (← links)
- Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase (Q28368030) (← links)
- Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors (Q28368032) (← links)
- Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89 (Q28378896) (← links)
- Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro (Q28379249) (← links)
- Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1. (Q30416860) (← links)
- A mutation at position 190 of human immunodeficiency virus type 1 reverse transcriptase interacts with mutations at positions 74 and 75 via the template primer (Q33690164) (← links)
- Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase (Q33757596) (← links)
- Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant (Q33782366) (← links)
- YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro. (Q33842803) (← links)
- A Ty1 reverse transcriptase active-site aspartate mutation blocks transposition but not polymerization (Q33842826) (← links)
- Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase (Q33843501) (← links)
- Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer (Q33845922) (← links)
- RNase H cleavage of the 5' end of the human immunodeficiency virus type 1 genome (Q33850257) (← links)
- 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA (Q33976617) (← links)
- Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. (Q34035941) (← links)
- Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants (Q34143613) (← links)
- Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. (Q34438247) (← links)
- Substitution of a highly basic helix/loop sequence into the RNase H domain of human immunodeficiency virus reverse transcriptase restores its Mn(2+)-dependent RNase H activity (Q34498422) (← links)
- Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function (Q34658171) (← links)
- Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase. (Q35104511) (← links)
- Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1. (Q35116619) (← links)
- Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription (Q35122784) (← links)
- Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. (Q35312562) (← links)
- Localization of the active site of the alpha subunit of the Escherichia coli DNA polymerase III holoenzyme (Q35631871) (← links)
- Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively (Q35859433) (← links)
- What is the orientation of DNA polymerases on their templates? (Q35859640) (← links)
- Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1 (Q35866621) (← links)
- Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. (Q35905947) (← links)
- Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis (Q35907177) (← links)
- Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity (Q36278914) (← links)
- Lys66 residue as a determinant of high mismatch extension and misinsertion rates of HIV-1 reverse transcriptase (Q36319882) (← links)
- Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1 (Q36630055) (← links)
- Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase (Q36635062) (← links)
- Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant (Q36645233) (← links)
- Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain (Q36650031) (← links)
- Sequence similarity between Borna disease virus p40 and a duplicated domain within the paramyxovirus and rhabdovirus polymerase proteins (Q36685230) (← links)
- Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase (Q36687547) (← links)
- Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase (Q36810415) (← links)